Germany โ€“ Medicines with the active ingredient rituximab - in the dosage form infusion solution concentrate (ATC: L01FA01)

By: Public Purchasing Data Service (responsible for the Procurement Office of the BMI)๐Ÿ“ GermanyOpen

Key Information

ReferenceGB-799123-2026
DeadlineOct 31, 2028 12:00 AM
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryGermany
AddressBonn, 53119, Germany
PublishedNov 17, 2026

Description

2. Procedure2.1.procedureTitle: Medicines with the active ingredient rituximab - in the dosage form infusion solution concentrate (ATC: L01FA01)Description: The subject of this publication is the conc...

Full details are available after unlocking this tender.